ATE414172T1 - Mikrobielle polynukleotide, die während der infekton eines wirts exprimiert werden - Google Patents

Mikrobielle polynukleotide, die während der infekton eines wirts exprimiert werden

Info

Publication number
ATE414172T1
ATE414172T1 AT00952514T AT00952514T ATE414172T1 AT E414172 T1 ATE414172 T1 AT E414172T1 AT 00952514 T AT00952514 T AT 00952514T AT 00952514 T AT00952514 T AT 00952514T AT E414172 T1 ATE414172 T1 AT E414172T1
Authority
AT
Austria
Prior art keywords
antigens
infection
expressed
microbial
during
Prior art date
Application number
AT00952514T
Other languages
English (en)
Inventor
Ann Progulske-Fox
Martin Handfield
L Brady
Jeffrey Hillman
Original Assignee
Oragenics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oragenics Inc filed Critical Oragenics Inc
Application granted granted Critical
Publication of ATE414172T1 publication Critical patent/ATE414172T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1072—Differential gene expression library synthesis, e.g. subtracted libraries, differential screening
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT00952514T 1999-08-06 2000-08-04 Mikrobielle polynukleotide, die während der infekton eines wirts exprimiert werden ATE414172T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14755199P 1999-08-06 1999-08-06

Publications (1)

Publication Number Publication Date
ATE414172T1 true ATE414172T1 (de) 2008-11-15

Family

ID=22522023

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00952514T ATE414172T1 (de) 1999-08-06 2000-08-04 Mikrobielle polynukleotide, die während der infekton eines wirts exprimiert werden

Country Status (13)

Country Link
US (1) US8034571B1 (de)
EP (1) EP1238102B1 (de)
AT (1) ATE414172T1 (de)
AU (1) AU778821B2 (de)
CA (1) CA2374156C (de)
DE (2) DE60040804D1 (de)
DK (1) DK1238102T3 (de)
ES (1) ES2184659T1 (de)
HK (1) HK1050029B (de)
IL (2) IL146544A0 (de)
MX (1) MXPA01012787A (de)
NZ (2) NZ531589A (de)
WO (1) WO2001011081A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6720139B1 (en) 1999-01-27 2004-04-13 Elitra Pharmaceuticals, Inc. Genes identified as required for proliferation in Escherichia coli
IL146544A0 (en) 1999-08-06 2002-07-25 Ivigene Corp Microbial polynucleotides expressed during infection of a host
US7033748B2 (en) * 1999-08-06 2006-04-25 Ivigene Corporation Identification of microbial polynucleotides expressed during infection of a host
AT410798B (de) * 2001-01-26 2003-07-25 Cistem Biotechnologies Gmbh Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
US7052860B2 (en) 2001-11-28 2006-05-30 University Of Florida Research Foundation Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
WO2004045499A2 (en) * 2002-11-20 2004-06-03 University Of Florida Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
JP2006519586A (ja) * 2002-11-20 2006-08-31 ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インコーポレイティド 歯周疾患の診断、治療、およびモニタリングのためのアクチノバチルス・アクチノミセテムコミタンス抗原の同定
EP1660524B1 (de) 2003-08-15 2011-01-12 University of Florida Research Foundation, Inc. Die identifikation von polynukleotiden von porphyromonas gingivalis-virulenz zur diagnose, behandlung und beobachtung von periodontalerkrankungen
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789157A (en) * 1990-06-11 1998-08-04 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: tissue selex
US20040247611A1 (en) 1994-05-23 2004-12-09 Montana State University Identification of pathogen-ligand interactions
US6013443A (en) * 1995-05-03 2000-01-11 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: tissue SELEX
ATE252602T1 (de) 1996-08-27 2003-11-15 Chiron Corp Meningokokkus b-epitop ausbildende monoklonale antikoerper und deren verwendung zur herstellung von impfstoffzusammenstellungen
AU6240198A (en) * 1997-01-09 1998-08-03 Whitehead Institute For Biomedical Research Subtractive antibody screening (sas) and uses therefor
AU7128098A (en) 1997-04-15 1998-11-11 Barnes-Jewish Hospital Methods of obtaining antigens specific for fungi, antibodies for such antigens, and diagnosis of disease using such antigens and/or antibodies
US6040144A (en) 1997-07-25 2000-03-21 Mount Sinai School Of Medicine Procedure for preparing gene expression libraries enriched for secretory protein genes
WO1999015897A1 (en) * 1997-09-19 1999-04-01 Chiron Corporation Subtractive protein screening for gene identification
US6514694B2 (en) 1997-12-19 2003-02-04 Heska Corporation Methods for the detection of encysted parasites
IL146544A0 (en) 1999-08-06 2002-07-25 Ivigene Corp Microbial polynucleotides expressed during infection of a host

Also Published As

Publication number Publication date
ES2184659T1 (es) 2003-04-16
MXPA01012787A (es) 2005-08-26
IL146544A0 (en) 2002-07-25
CA2374156C (en) 2008-01-29
HK1050029A1 (en) 2003-06-06
WO2001011081A3 (en) 2002-07-11
NZ531589A (en) 2005-08-26
HK1050029B (zh) 2009-03-27
EP1238102B1 (de) 2008-11-12
EP1238102A2 (de) 2002-09-11
DE60040804D1 (de) 2008-12-24
CA2374156A1 (en) 2001-02-15
US8034571B1 (en) 2011-10-11
IL146544A (en) 2008-11-26
WO2001011081A2 (en) 2001-02-15
DE1238102T1 (de) 2003-05-28
AU6519700A (en) 2001-03-05
NZ515553A (en) 2005-01-28
AU778821B2 (en) 2004-12-23
DK1238102T3 (da) 2009-02-09

Similar Documents

Publication Publication Date Title
DE60040804D1 (de) Mikrobielle polynukleotide, die während der infekton eines wirts exprimiert werden
EP1731166A3 (de) Streptococcus pneumoniae Proteine und Impfstoffe
EA200100565A1 (ru) Новые стрептококковые антигены
NZ330887A (en) Monoclonals and polyclonals antibodies for the diagnosis of breast cancer
WO2005062972A3 (en) Treatment of cancer with novel anti-il 13 monoclonal antibodies
JP2008285675A (ja) 修飾したメニンゴコッカスのポリサッカライドを結合したワクチン
HUP0102304A1 (hu) B Csoportba tartozó Streptococcus antigének
FR2632956B2 (fr) Sondes a papillomavirus hpv49, hpv50, hpv54, hpv55; produits genetiquement et immunologiquement lies a ce papillomavirus hpv49, hpv50, hpv54, hpv55; procede de diagnostic in vitro d'infections a papillomavirus et d'immunisation in vivo contre ces papillomavirus
WO1998045328A3 (en) Compositions and methods for the treatment and diagnosis of breast cancer
CA2217522A1 (en) Isolated frpb nucleic acid molecule and vaccine
EA200100700A1 (ru) Гены и белки и их применение
AU548623B2 (en) Production of antibodies
FR2781158B1 (fr) Nouvelles proteines modifiees immunogenes non immunosuppressives, leur procede de preparation et leurs applications
JP6319927B2 (ja) Ｐｏｒｐｈｙｒｏｍｏｎａｓ ｇｕｌａｅの線毛タイプ
YU22202A (sh) Vakcina
MXPA01010186A (es) Composiciones y metodos para el tratamiento y diagnostico de cancer de mama.
Moskophidis et al. Molecular characterization of glycoprotein antigens on surface of Treponema pallidum: comparison with nonpathogenic Treponema phagedenis biotype Reiter
WO2004015063A3 (en) Amplification and overexpression of oncogenes
EA200100701A1 (ru) Белки наружной поверхности, их гены и их применение
JPH08208704A (ja) 新規な糖タンパク質複合体、その製造方法、並びに抗腫瘍剤、免疫調節剤及び増殖因子阻害剤
Ostapenko et al. Primary chemotherapy in conservative treatment of stage II breast cancer patients
HUP0303472A2 (hu) Eljárások pantotenát fokozott termelésére
Hampton COMPARISON OF HAEMOPHILUS INFLUENZAE TYPE B ISOLATES FROM HEALTHY CHILDREN IN THE GENERAL POPULATION AND DISEASED PATIENTS.
Durham THE RELATIONSHIP OF THREE EXTRACELLULAR PRODUCTS OF TYPE III GROUP B STREPTOCOCCI TO VIRULENCE IN A MOUSE MODEL.
Bollinger The pathogenicity of Cochlosoma anatis to ducklings.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties